Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cardiff Oncology Inc
CRDFCurrent price
1.26 USD
+0.04 USD (+3.28%)
Last closed
1.23 USD
Company
www.cardiffoncology.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
54 506 184 USD
Yield for 12 month
-19.23 %
Week
Month
Year
CRDF
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and hematologic malignancies, such as KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. It primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California. Address: 11055 Flintkote Avenue, San Diego, CA, United States, 92121
Analytics
WallStreet Target Price
8.5 USDP/E ratio
–Dividend Yield
–Current Year
+386 000 USD
Last Year
+359 000 USD
Current Quarter
+141 000 USD
Last Quarter
+108 000 USD
Current Year
+386 000 USD
Last Year
+359 000 USD
Current Quarter
+141 000 USD
Last Quarter
+108 000 USD
Key Figures CRDF
1 year
3 years
5 years
10 years
EBITDA
-44 091 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.21 %
PEG Ratio
–
Return On Equity TTM
-42.72 %
Wall Street Target Price
8.5 USD
Revenue TTM
460 000 USD
Book Value
1.74 USD
Revenue Per Share TTM
0.01 USD
Dividend Share
–
Quarterly Revenue Growth YOY
51.6 %
Dividend Yield
–
Gross Profit TTM
-26 721 000 USD
Earnings Share
-0.92 USD
Diluted Eps TTM
-0.92 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CRDF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CRDF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:6
Payout Ratio
–
Last Split Date
20.02.2019
Dividend Date
20.02.2019
Stock Valuation CRDF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
482.7446
Price Sales TTM
159.9695
Enterprise Value EBITDA
-9.3784
Price Book MRQ
0.5643
Financials CRDF
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators CRDF
For 52 weeks
0.94 USD
2.79 USD
50 Day MA
1.23 USD
Shares Short Prior Month
1 528 003
200 Day MA
1.56 USD
Short Ratio
4.65
Shares Short
1 626 822
Short Percent
3.75 %
Google
Apple
Facebook